在人类癌症中,MARK2/MARK3基因酶是YAP/TAZ的催化共依存
Olaf Klingbeil1, Damianos Skopelitis1, Claudia Tonelli1
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
Cancer discovery
|July 26, 2024
概括
研究人员确定MARK2/3激酶对于癌症中YAP/TAZ功能至关重要. 通过基于CagA的抑制剂向这些激酶可以使瘤回归,这表明Hippo途径失调的癌症的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 信号转导 信号转导
背景情况:
- 在人类癌症中,Hippo信号通路经常失调,从而产生对YAP/TAZ转录协活性剂的依赖.
- 了解YAP/TAZ的调节机制对于开发向癌症疗法至关重要.
研究的目的:
- 使用CRISPR屏幕识别YAP/TAZ功能关键的激酶.
- 研究MARK2/3激酶作为YAP/TAZ驱动癌症的潜在治疗点.
主要方法:
- 采用并行向CRISPR屏来识别YAP/TAZ活动的必需激酶.
- 杆菌的CagA蛋白被调整为MARK2/3激酶的催化抑制剂.
- 在抑制MARK2/3.3后,瘤回归在体内被评估.
主要成果:
- 鉴定MARK2/3激酶对于YAP/TAZ功能在各种癌症和肉瘤类型中至关重要.
- 马克2/3直接酸化NF2和YAP/TAZ,抵消LATS1/2.2.的瘤抑制活性.
- 使用基于CagA的策略抑制MARK2/3导致实体内已建立瘤的回归.
结论:
- 在癌症中,MARK2/3激酶对YAP/TAZ具有关键的依赖性.
- 向MARK2/3提供了一种潜在的治疗途径,以恢复YAP/TAZ失调癌症中的Hippo通路瘤抑制.
- 这项研究强调了遗传冗余如何掩盖癌症治疗中的关键信号依赖性.
更多相关视频
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
10.8K
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.0K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
